Argent BioPharma (PK)【RGTLF】銘柄情報

Argent BioPharma Ltd (PK) (RGTLF) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.025

( - )

買値

0.0001

売値

596,000.06

出来高

平均取引量 (3 か月)

US$ 74,548

財務取引量

0.00 日の範囲 0.00

0.01 52 週間の範囲 0.153

時価総額

2.085M

企業価値

10.07M

前日終値

0.025

始値

時刻

最終取引時間

VWAP

歳入

347.78k

純利益

-8.62M

発行済株式数

83,384,867

浮動株比率 (%)

34.36%

機関投資家保有比率 (%)

1.00%

配当利回り

PER

-0.29

株価売上高倍率 (PSR)

11.5

1 株当たり利益 (EPS)

-0.12

ベータ

0.41

Argent BioPharma Limited, a clinical-stage biopharmaceutical company, develops nano-engineered therapeutics that reset the balance between the nervous and immune systems in Malta, Slovenia, Australia, and internationally. The company’s principal product candidates include CimetrA, which is in phase ... Argent BioPharma Limited, a clinical-stage biopharmaceutical company, develops nano-engineered therapeutics that reset the balance between the nervous and immune systems in Malta, Slovenia, Australia, and internationally. The company’s principal product candidates include CimetrA, which is in phase III clinical trial for the treatment of acute lung injury and ARDS; CannEpil, which is in phase I clinical trial for refractory epilepsy; and CogniCann, which is in phase IIA clinical trial for the symptomatic relief of Dementia and Alzheimer’s. It is also involved in the preclinical development of Irnican for the treatment of Glioblastoma Multiforme; and R&D, which focuses on wound treatment. The company has collaborated with SINTEF to enhance antimicrobial therapies for chronic wounds and potential oncologic wound care. The company was formerly known as MGC Pharmaceuticals Limited and changed its name to Argent BioPharma Limited. Argent BioPharma Limited was founded in 2014 and is based in Subiaco, Australia. 詳細を表示

セクター

Healthcare

業界

Pharmaceuticals

ウェブサイト

argentbiopharma.com

本社

Subiaco, Australia

設立

2026

Argent BioPharma Ltd (PK) is listed in the Healthcare sector of the その他OTC with ticker RGTLF. The last closing price for Argent BioPharma (PK) was US$0.03. Over the last year, Argent BioPharma (PK) shares have traded in a share price range of US$ 0.01 to US$ 0.153.

Argent BioPharma (PK) currently has 83,384,867 shares in issue. The market capitalisation of Argent BioPharma (PK) is US$2.08 million. Argent BioPharma (PK) has a price to earnings ratio (PE ratio) of -0.29.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	-0.0164	-39.61352657	0.0414	0.0414	0.01	1445	0.02636839	CS
26	-0.04	-61.5384615385	0.065	0.065	0.01	1762	0.03670495	CS
52	0.0145	138.095238095	0.0105	0.153	0.01	9148	0.06969757	CS
156	-0.1875	-88.2352941176	0.2125	0.5683	0.01	56924	0.19510357	CS
260	-0.1875	-88.2352941176	0.2125	0.5683	0.01	56924	0.19510357	CS